Edurant

Monthly shots control HIV as well as daily pills in two big studies
Stat
Thu, 03/7/19 - 09:21 pm
HIV
AIDS
JNJ
Janssen
ViiV Healthcare
cabotegravir
Edurant
Should Gilead Be Worried About This New Monthly HIV Medication?
Motley Fool
Thu, 08/16/18 - 10:09 am
Gilead Sciences
HIV
JNJ
ViiV
cabotegravir
rilpivirine
Edurant
GlaxoSmithKline gambles against Gilead with risky bet on two-drug HIV combos
Fierce Pharma
Wed, 09/7/16 - 09:37 am
GSK
Gilead Sciences
HIV
Tivicay
Edurant
Janssen
ViiV
Innovations In HIV: Johnson & Johnson, Glaxo Vs. Gilead
Seeking Alpha
Mon, 07/22/13 - 10:26 am
HIV
Atripla
JNJ
Pfizer
GSK
Gilead
Dolutegravir
Edurant
China
TMC310911
J&J, Gilead HIV Drug Wins FDA Approval
Bloomberg
Wed, 08/10/11 - 05:28 pm
Gilead
JNJ
Complera
HIV
FDA
Edurant
Truvada
Johnson & Johnson Touts Growth From New Drugs Zytiga, Edurant
Minyanville
Fri, 05/27/11 - 08:53 am
JNJ
Edurant
Zytiga
prostate cancer
HIV
AIDS
FDA approves new HIV drug from Johnson & Johnson
Yahoo/AP
Fri, 05/20/11 - 12:15 pm
HIV
FDA
JNJ
Edurant